Neurotensin receptors in pancreatic ductal carcinomas

EJNMMI Research

Table 2 Quantification of NT-R in PanIN 1B, 2, and 3 and in concomitant invasive pancreatic carcinoma

Patient number	PanIN 1B	PanIN 2	PanIN 3	Invasive ductal carcinoma ^b
29	-	1,882 (1,732;1,923)^a	-	-
30	-	-	5,809 (5,937;5,681)^a	1,257 (1,290;1,223)^a
31	0	-	-	-
32	0	0	0	0
33	-	>10,000 (>10,000;>10,000)^a	9,871 (9,741;10,000)^a	8,769 (8,885;8,652)^a
34	0	-	1,937 (1,881;1,992)^a	1,651 (1,759;1,542)^a
35	-	0	3,103 (3,209;2,996)^a	2,539 (2,771;2,306)^a
36	0	0	-	-
37	0	-	9,988 (9,976;10,000)^a	>10,000 (>10,000;>10,000)^a
38	0	0	0	0
Mean ± SEM of positive cases	0	5,914 ± 4,086	6,142 ± 1,669	4,843 ± 1,876

Values represent neurotensin receptor density (dpm/mg tissue). ^aIn addition to the displacement by neurotensin, full displacement by SR48692 was observed in these tissues. ^bThese cases are different from those listed in Table 1. Hyphen (−) means no corresponding tissue available.